The Chinese government unveiled a program to woo foreign talent just as the US cracked down on H-1Bs with a $100,000 fee. The ...
Indian students face challenges studying abroad due to Trump administration policies, but U.S. universities still offer ...
A landmark study in China covering 42,703 families affected by rare diseases across 32 provincial regions of China has established a new diagnosis framework for rare diseases. It offers new hope to ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from Stage A of a Phase 3 study in China sponsored ...
A new analysis found that nearly 700 drugs approved for use in the United States depend on chemicals solely produced in China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results